Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bachelot

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 25, 2017
[Antiplatelet agents and transfusion]P Gaussem, A-C Martin, T Belleville-Rolland, et al.
La Nouvelle Presse Medicale|May 15, 1976
[Trial of androgen therapy in the treatment of non-lymphoblastic acute leukemia. First results]D Hollard, J J Sotto, C Bachelot, et al.
British Journal of Haematology|June 1, 1997
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeD Lasne, R Saffroy, C Bachelot, et al.
Biochemical Pharmacology|September 1, 1992
Inhibition of platelet activation by tyrosine kinase inhibitorsF Rendu, A Eldor, F Grelac, et al.
The Journal of Biological Chemistry|May 12, 1995
Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregationT J Kovacsovics, C Bachelot, A Toker, et al.
The Biochemical Journal|June 15, 1992
Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitorsC Bachelot, E Cano, F Grelac, et al.
Archives Francaises De Pediatrie|August 1, 1983
[Erythroblastopenia in a child with immune deficiency and hyper IgM]C Bachelot, P François, M Bost, et al.
FEBS Letters|July 14, 1999
Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activationS Pain, A Monstero-Lastres, H Falet, et al.
Journal of Thrombosis and Haemostasis : JTH|December 31, 2009
Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjectsJ-S Hulot, G Wuerzner, C Bachelot-Loza, et al.
The Journal of Biological Chemistry|December 8, 1995
Phosphorylation of the platelet p47 phosphoprotein is mediated by the lipid products of phosphoinositide 3-kinaseA Toker, C Bachelot, C S Chen, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 25, 2017
[Antiplatelet agents and transfusion]P Gaussem, A-C Martin, T Belleville-Rolland, et al.
La Nouvelle Presse Medicale|May 15, 1976
[Trial of androgen therapy in the treatment of non-lymphoblastic acute leukemia. First results]D Hollard, J J Sotto, C Bachelot, et al.
British Journal of Haematology|June 1, 1997
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeD Lasne, R Saffroy, C Bachelot, et al.
Biochemical Pharmacology|September 1, 1992
Inhibition of platelet activation by tyrosine kinase inhibitorsF Rendu, A Eldor, F Grelac, et al.
The Journal of Biological Chemistry|May 12, 1995
Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregationT J Kovacsovics, C Bachelot, A Toker, et al.
The Biochemical Journal|June 15, 1992
Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitorsC Bachelot, E Cano, F Grelac, et al.
Archives Francaises De Pediatrie|August 1, 1983
[Erythroblastopenia in a child with immune deficiency and hyper IgM]C Bachelot, P François, M Bost, et al.
FEBS Letters|July 14, 1999
Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activationS Pain, A Monstero-Lastres, H Falet, et al.
Journal of Thrombosis and Haemostasis : JTH|December 31, 2009
Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjectsJ-S Hulot, G Wuerzner, C Bachelot-Loza, et al.
The Journal of Biological Chemistry|December 8, 1995
Phosphorylation of the platelet p47 phosphoprotein is mediated by the lipid products of phosphoinositide 3-kinaseA Toker, C Bachelot, C S Chen, et al.
Pageof 6